Published in Lancet on January 31, 1998
Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax (2000) 5.14
Modelling the influence of human behaviour on the spread of infectious diseases: a review. J R Soc Interface (2010) 3.71
Vaccination and the theory of games. Proc Natl Acad Sci U S A (2004) 2.89
MMR vaccination and autism 1998. BMJ (1998) 2.89
Concerns about immunisation. BMJ (2000) 2.80
Vaccine criticism on the World Wide Web. J Med Internet Res (2005) 2.25
Imitation dynamics predict vaccinating behaviour. Proc Biol Sci (2005) 2.02
Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys. Br J Gen Pract (2002) 2.00
Vaccine hesitancy: an overview. Hum Vaccin Immunother (2013) 1.96
Social contact networks and disease eradicability under voluntary vaccination. PLoS Comput Biol (2009) 1.96
Immunisation policy: from compliance to concordance? Br J Gen Pract (2003) 1.86
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Antivaccination activists on the world wide web. Arch Dis Child (2002) 1.74
Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61
The influence of social norms on the dynamics of vaccinating behaviour for paediatric infectious diseases. Proc Biol Sci (2014) 1.55
Contagious diseases in the United States from 1888 to the present. N Engl J Med (2013) 1.54
Beyond Rational Decision-Making: Modelling the Influence of Cognitive Biases on the Dynamics of Vaccination Coverage. PLoS One (2015) 1.39
The epidemiology of pertussis in Germany: past and present. BMC Infect Dis (2009) 1.31
Retracted Recursive fury: conspiracist ideation in the blogosphere in response to research on conspiracist ideation. Front Psychol (2013) 1.28
MMR vaccine: the continuing saga. BMJ (2001) 1.27
Individual freedoms versus collective responsibility: immunization decision-making in the face of occasionally competing values. Emerg Themes Epidemiol (2006) 1.12
Vaccination policies: individual rights v community health. We can't afford to be half hearted about vaccination programmes. BMJ (1999) 1.03
Factors influencing African-American mothers' concerns about immunization safety: a summary of focus group findings. J Natl Med Assoc (2005) 1.02
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine (2009) 1.02
Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity. Proc Natl Acad Sci U S A (2013) 1.01
Vaccination rates in a multicultural population. Arch Dis Child (2005) 0.92
The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA. Microbiology (2012) 0.91
Vaccine hesitancy: understanding better to address better. Isr J Health Policy Res (2016) 0.91
Postpartum mothers' attitudes, knowledge, and trust regarding vaccination. Matern Child Health J (2007) 0.89
An account of collective actions in public health. Am J Public Health (2009) 0.89
Information is in the eye of the beholder: Seeking information on the MMR vaccine through an Internet search engine. AMIA Annu Symp Proc (2014) 0.88
Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci U S A (2015) 0.88
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis (2014) 0.87
Cognitive biases can affect moral intuitions about cognitive enhancement. Front Syst Neurosci (2014) 0.86
Resolving pertussis immunity and vaccine effectiveness using incidence time series. Expert Rev Vaccines (2012) 0.86
Licensed pertussis vaccines in the United States. History and current state. Hum Vaccin Immunother (2014) 0.84
Interacting and paradoxical forces in neuroscience and society. Nat Rev Neurosci (2007) 0.83
Sustaining Vaccine Confidence in the 21st Century. Vaccines (Basel) (2013) 0.83
Parents' experiences discussing pediatric vaccination with healthcare providers: a survey of Canadian naturopathic patients. PLoS One (2011) 0.82
Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children. Eur J Epidemiol (2003) 0.81
High effective coverage of vector control interventions in children after achieving low malaria transmission in Zanzibar, Tanzania. Malar J (2013) 0.81
Prevalence of SCN1A-related dravet syndrome among children reported with seizures following vaccination: a population-based ten-year cohort study. PLoS One (2013) 0.80
The District Immunisation Coordinator. Arch Dis Child (2000) 0.80
Parents' perceived vulnerability and perceived control in preventing Meningococcal C infection: a large-scale interview study about vaccination. BMC Public Health (2008) 0.79
Support for immunization registries among parents of vaccinated and unvaccinated school-aged children: a case control study. BMC Public Health (2006) 0.79
Bounded rationality alters the dynamics of paediatric immunization acceptance. Sci Rep (2015) 0.79
Game theory of pre-emptive vaccination before bioterrorism or accidental release of smallpox. J R Soc Interface (2015) 0.77
Association between sudden infant death syndrome and diphtheria-tetanus-pertussis immunisation: an ecological study. BMC Pediatr (2015) 0.77
The resurgence of mumps and pertussis. Hum Vaccin Immunother (2016) 0.77
The Economic Value of Vaccination: Why Prevention is Wealth. J Mark Access Health Policy (2015) 0.75
Doing well still needs to sell: Bringing vaccine-preventable diseases under further control in Canada requires a shift in thinking. Paediatr Child Health (1999) 0.75
We must not lose the wonders of vaccination. MedGenMed (2005) 0.75
Enhancing vaccine safety capacity globally: A lifecycle perspective. Vaccine (2015) 0.75
Manipulating Google's Knowledge Graph Box to Counter Biased Information Processing During an Online Search on Vaccination: Application of a Technological Debiasing Strategy. J Med Internet Res (2016) 0.75
Above all, do no harm: assessing the risk of an adverse reaction. West J Med (2001) 0.75
Influenza newspaper reports and the influenza epidemic: an observational study in Fukuoka City, Japan. BMJ Open (2015) 0.75
Safety assessment of adjuvanted vaccines: Methodological considerations. Hum Vaccin Immunother (2015) 0.75
Vaccination and type 1 diabetes mellitus. BMJ (1999) 0.75
Factors related to non-compliance to HPV vaccination in Roraima-Brazil: a region with a high incidence of cervical cancer. BMC Health Serv Res (2016) 0.75
The impact of a vaccine scare on parental views, trust and information needs: a qualitative study in Sydney, Australia. BMC Public Health (2017) 0.75
From population to public institutions: what needs to be changed to benefit from the full value of vaccination. J Mark Access Health Policy (2015) 0.75
Vaccines, encephalopathies, and mutations. Epilepsy Curr (2007) 0.75
Parental attitudes towards measles vaccination in the canton of Aargau, Switzerland: a latent class analysis. BMC Infect Dis (2016) 0.75
The Heart Trumps the Head: Desirability Bias in Political Belief Revision. J Exp Psychol Gen (2017) 0.75
No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. Curr Opin Immunol (2017) 0.75
Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea. Clin Exp Vaccine Res (2017) 0.75
Comparing human papillomavirus vaccine concerns on Twitter: a cross-sectional study of users in Australia, Canada and the UK. BMJ Open (2017) 0.75
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet (1999) 11.10
The new measles campaign. BMJ (1994) 6.59
Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making (2000) 4.86
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet (1982) 4.56
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst (1977) 4.28
Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ (1994) 4.10
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet (1995) 3.93
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Cell migration inhibition factor released by antigen from human peripheral lymphocytes. Nature (1968) 3.62
Oral zinc in macular degeneration. Arch Ophthalmol (1988) 3.58
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet (2001) 3.19
SEX DIFFERENCES IN KIDNEY MORPHOLOGY AND CHLOROFORM NECROSIS. Science (1945) 3.18
Surveillance of antibody to measles, mumps, and rubella by age. BMJ (1988) 3.11
Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest (1996) 3.10
Treatment of Early Mammary Carcinoma: A Cooperative International Study. Ann Surg (1963) 3.07
Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med (1981) 2.89
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection. Infect Immun (2001) 2.86
Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J Clin Invest (1999) 2.81
Congenital rubella in babies of south Asian women in England and Wales: an excess and its causes. Br Med J (Clin Res Ed) (1987) 2.81
Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol (1996) 2.65
Carcinoembryonic antigen (CEA) assay. A laboratory adjunct in the diagnosis and management of cancer. Hum Pathol (1974) 2.57
Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. J Infect Dis (2000) 2.57
Rubella vaccination in the UK: time for a complete strategy. Lancet (1985) 2.54
Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial. Arch Gen Psychiatry (2001) 2.51
Varicella-zoster virus epidemiology--a changing scene? J Infect Dis (1996) 2.48
Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ (1989) 2.48
Effect of selective vaccination on rubella susceptibility and infection in pregnancy. Br Med J (Clin Res Ed) (1985) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
Shift in age in chickenpox. Lancet (1993) 2.46
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A (1995) 2.44
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet (1994) 2.43
Projections of AIDS morbidity and mortality in San Francisco. JAMA (1990) 2.42
Cell position and light influence C4 versus C3 patterns of photosynthetic gene expression in maize. EMBO J (1988) 2.37
Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. J Infect Dis (2000) 2.35
Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32
Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis (1998) 2.26
Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. J Infect Dis (1999) 2.16
Varicella in maternity units. Lancet (1990) 2.16
Rubella susceptibility and the continuing risk of infection in pregnancy. Br Med J (Clin Res Ed) (1987) 2.13
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
Confounding in studies of adverse reactions to vaccines. Am J Epidemiol (1992) 2.06
The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. J Infect Dis (1999) 2.04
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem (2000) 2.02
Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull World Health Organ (1984) 1.99
Fat embolism prophylaxis with corticosteroids. A prospective study in high-risk patients. Ann Intern Med (1983) 1.99
Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect (1995) 1.89
Pre-eclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet (1994) 1.88
Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb Vasc Biol (1995) 1.88
Vasopressin in prevention of lumbar puncture headache. Br Med J (1968) 1.85
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84
Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health (2001) 1.83
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80
The Support of Research in Medical and Allied Fields for the Period 1946 through 1951. Science (1952) 1.80
Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J Clin Invest (1991) 1.79
Impact of meningococcal C conjugate vaccine in the UK. J Med Microbiol (2002) 1.77
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA (1991) 1.69
Increased blood pressure during potassium depletion in normotensive men. N Engl J Med (1989) 1.69
Influence of age on pain relief from analgesics. A study of postoperative patients. JAMA (1971) 1.68
Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child (1984) 1.67
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine (2007) 1.66
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest (1996) 1.65
Thyroid carcinoma in single cold nodules and in cold nodules of multinodular goiters. Endocr Pract (2001) 1.64
Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64
Surveillance of symptoms following MMR vaccine in children. Practitioner (1989) 1.63
Severe and unrecognised: pertussis in UK infants. Arch Dis Child (2003) 1.62
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol (2009) 1.59
Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis (1988) 1.57
Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol (1998) 1.57
Ten years of serological surveillance in England and Wales: methods, results, implications and action. Int J Epidemiol (2000) 1.55
The Drosophila Polycomb group gene Sex comb on midleg (Scm) encodes a zinc finger protein with similarity to polyhomeotic protein. Development (1996) 1.54
Injection safety: a global challenge. Bull World Health Organ (1999) 1.52
Pyrexia after diphtheria/tetanus/pertussis and diphtheria/tetanus vaccines. Arch Dis Child (1983) 1.52
The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). Proc Natl Acad Sci U S A (1997) 1.51
Simple and choice reaction time following severe head injury. Cortex (1970) 1.51
Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis (1997) 1.50
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Rational programme for screening travellers for antibodies to hepatitis A virus. Lancet (1988) 1.50
Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options. Epidemiol Infect (1995) 1.50
Operative transluminal balloon angioplasty. Adjunct to coronary bypass for extended myocardial revascularization of more than 3000 lesions in 1000 patients. J Thorac Cardiovasc Surg (1990) 1.49
Endoplasmic reticulum stress proteins block oxidant-induced Ca2+ increases and cell death. J Biol Chem (1998) 1.49
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect (2000) 1.48
Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health (2009) 1.48
A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A (1995) 1.47
Congenital rubella in the Asian community in Britain. BMJ (1990) 1.46
Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella [corrected]. BMJ (1996) 1.46
Cancelled elective operations: an observational study from a district general hospital. J Health Organ Manag (2007) 1.45
Diphtheria in the United States, 1971-81. Am J Public Health (1985) 1.44